Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Colebunders

Showing results (21-30 of 480) with videos related to

Pageof 48
Sort By:
Lancet (London, England)|November 16, 2024
Nakalanga syndrome and hypopituitarismBenjamin De Wilde, Robert Colebunders
Infectious Diseases of Poverty|March 29, 2025
Recognising the neurological burden of onchocerciasis: the need to include onchocerciasis-associated epilepsy in onchocerciasis global health metricsLuís-Jorge Amaral, Robert Colebunders
Plos Clinical Trials|March 3, 2007
Quality of life in HIV clinical trials: why sexual health must not be ignoredOlivier Koole, Christiana Noestlinger, Robert Colebunders
The Lancet. Infectious Diseases|March 27, 2015
Filovirus epidemic in 1956 in Bili, DRCRobert Colebunders, Jef Van den Ende
International Journal of Dermatology|January 5, 2008
Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African womanCatherina Kigonya, Fred Lutwama, Robert Colebunders
Current Opinion in Pulmonary Medicine|April 12, 2003
Current thinking on the management of tuberculosisIvan Bastian, Rick Stapledon, Robert Colebunders
American Journal of Obstetrics and Gynecology|May 11, 2013
The global epidemiology of bacterial vaginosis: a systematic reviewChris Kenyon, Robert Colebunders, Tania Crucitti
AIDS (London, England)|May 16, 2007
When to switch for antiretroviral treatment failure in resource-limited settings?Marc Vekemans, Laurence John, Robert Colebunders
Pathogens (Basel, Switzerland)|November 24, 2022
COVID-19 in Low and Middle Income CountriesRobert Colebunders, Joseph Nelson Siewe Fodjo
Neuroepidemiology|March 26, 2024
Nodding Syndrome Associated with OnchocerciasisRobert Colebunders, Joseph Nelson Siewe Fodjo
Pageof 48

Showing results (21-30 of 480) with videos related to

Sort By:
Pageof 48
Lancet (London, England)|November 16, 2024
Nakalanga syndrome and hypopituitarismBenjamin De Wilde, Robert Colebunders
Infectious Diseases of Poverty|March 29, 2025
Recognising the neurological burden of onchocerciasis: the need to include onchocerciasis-associated epilepsy in onchocerciasis global health metricsLuís-Jorge Amaral, Robert Colebunders
Plos Clinical Trials|March 3, 2007
Quality of life in HIV clinical trials: why sexual health must not be ignoredOlivier Koole, Christiana Noestlinger, Robert Colebunders
The Lancet. Infectious Diseases|March 27, 2015
Filovirus epidemic in 1956 in Bili, DRCRobert Colebunders, Jef Van den Ende
International Journal of Dermatology|January 5, 2008
Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African womanCatherina Kigonya, Fred Lutwama, Robert Colebunders
Current Opinion in Pulmonary Medicine|April 12, 2003
Current thinking on the management of tuberculosisIvan Bastian, Rick Stapledon, Robert Colebunders
American Journal of Obstetrics and Gynecology|May 11, 2013
The global epidemiology of bacterial vaginosis: a systematic reviewChris Kenyon, Robert Colebunders, Tania Crucitti
AIDS (London, England)|May 16, 2007
When to switch for antiretroviral treatment failure in resource-limited settings?Marc Vekemans, Laurence John, Robert Colebunders
Pathogens (Basel, Switzerland)|November 24, 2022
COVID-19 in Low and Middle Income CountriesRobert Colebunders, Joseph Nelson Siewe Fodjo
Neuroepidemiology|March 26, 2024
Nodding Syndrome Associated with OnchocerciasisRobert Colebunders, Joseph Nelson Siewe Fodjo
Pageof 48